Download PDF
CC BY 4.0 · Aorta (Stamford) 2017; 05(01): 11-20
DOI: 10.12945/j.aorta.2017.17.003
State-of-the-Art Review
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genes Associated with Thoracic Aortic Aneurysm and Dissection

An Update and Clinical Implications
Adam J. Brownstein
1   Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut, USA
,
Bulat A. Ziganshin
1   Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut, USA
,
Helena Kuivaniemi
2   Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, and Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
,
Simon C. Body
3   Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
,
Allen E. Bale
4   Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA
,
John A. Elefteriades
1   Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut, USA
› Author Affiliations
Further Information

Publication History

06 January 2017

06 January 2017

Publication Date:
24 September 2018 (online)

   Permissions and Reprints

Abstract

Thoracic aortic aneurysm (TAA) is a lethal disease, with a natural history of enlarging progressively until dissection or rupture occurs. Since the discovery almost 20 years ago that ascending TAAs are highly familial, our understanding of the genetics of thoracic aortic aneurysm and dissection (TAAD) has increased exponentially. At least 29 genes have been shown to be associated with the development of TAAD, the majority of which encode proteins involved in the extracellular matrix, smooth muscle cell contraction or metabolism, or the transforming growth factor-β signaling pathway. Almost one-quarter of TAAD patients have a mutation in one of these genes. In this review, we provide a summary of TAAD-associated genes, associated clinical features of the vasculature, and implications for surgical treatment of TAAD. With the widespread use of next-generation sequencing and development of novel functional assays, the future of the genetics of TAAD is bright, as both novel TAAD genes and variants within the genes will continue to be identified.

Key Words

Thoracic aortic aneurysm and dissection (TAAD) - Genetics - Aortic aneurysm
 

  • References

  • 1 Ramanath VS, Oh JK, Sundt 3rd TM, Eagle KA. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clinic Proc 2009; 84: 465-481 . DOI: 10.1016/S0025-6196(11)60566-1
    CrossrefPubMedGoogle Scholar
  • 2 Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM. , et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337-339 . DOI: 10.1038/352337a0
    CrossrefPubMedGoogle Scholar
  • 3 Biddinger A, Rocklin M, Coselli J, Milewicz DM. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 1997; 25: 506-511 . DOI: 10.1016/S0741-5214(97)70261-1
    CrossrefPubMedGoogle Scholar
  • 4 Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA. , et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999; 134: 361-367 . DOI: 10.1001/archsurg.134.4.361
    PubMedGoogle Scholar
  • 5 Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Card 2010; 55: 841-857 . DOI: 10.1016/j.jacc.2009.08.084
    CrossrefPubMedGoogle Scholar
  • 6 Milewicz D, Hostetler E, Wallace S, Mellor-Crummey L, Gong L, Pannu H. , et al. Precision medical and surgical management for thoracic aortic aneurysms and acute aortic dissections based on the causative mutant gene. J Cardiovasc Surg (Torino) 2016; 57: 172-177 . PMID: 26837258
    PubMedGoogle Scholar
  • 7 Karimi A, Milewicz DM. Structure of the elastin-contractile units in the thoracic aorta and how genes that cause thoracic aortic aneurysms and dissections disrupt this structure. Can J Cardiol 2016; 32: 26-34 . DOI: 10.1016/j.cjca.2015.11.004
    CrossrefPubMedGoogle Scholar
  • 8 Isselbacher EM, Lino Cardenas CL, Lindsay ME. Hereditary influence in thoracic aortic aneurysm and dissection. Circulation 2016; 133: 2516-2528 . DOI: 10.1161/CIRCULATIONAHA.116.009762
    CrossrefPubMedGoogle Scholar
  • 9 Bradley TJ, Bowdin SC, Morel CF, Pyeritz RE. The expanding clinical spectrum of extracardiovascular and cardiovascular manifestations of heritable thoracic aortic aneurysm and dissection. Can J Cardiol 2016; 32: 86-99 . DOI: 10.1016/j.cjca.2015.11.007
    CrossrefPubMedGoogle Scholar
  • 10 Andelfinger G, Loeys B, Dietz H. A decade of discovery in the genetic understanding of thoracic aortic disease. Can J Cardiol 2016; 32: 13-25 . DOI: 10.1016/j.cjca.2015.10.017
    CrossrefPubMedGoogle Scholar
  • 11 Luyckx I, Loeys BL. The genetic architecture of non-syndromic thoracic aortic aneurysm. Heart 2015; 101: 1678-1684 . DOI: 10.1136/heartjnl-2014-306381
    CrossrefPubMedGoogle Scholar
  • 12 Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg 2013; 2: 271-279 . DOI: 10.3978/j.issn.2225-319X.2013.05.12
    PubMedGoogle Scholar
  • 13 Gillis E, Van Laer L, Loeys BL. Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-beta signaling and vascular smooth muscle cell contractility. Circ Res 2013; 113: 327-340 . DOI: 10.1161/CIRCRESAHA.113.300675
    CrossrefPubMedGoogle Scholar
  • 14 Elefteriades JA, Pomianowski P. Practical genetics of thoracic aortic aneurysm. Prog Cardiovasc Dis 2013; 56: 57-67 . DOI: 10.1016/j.pcad.2013.06.002
    CrossrefPubMedGoogle Scholar
  • 15 Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M, Rizzo JA. , et al. Familial thoracic aortic aneurysms and dissections - Incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006; 82: 1400-1406 . DOI: 10.1016/j.athoracsur.2006.04.098
    CrossrefPubMedGoogle Scholar
  • 16 Milewicz DM, Chen H, Park ES, Petty EM, Zaghi H, Shashidhar G. , et al. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol 1998; 82: 474-479 . DOI: 10.1016/S0002-9149(98)00364-6
    CrossrefPubMedGoogle Scholar
  • 17 Kuivaniemi H, Ryer EJ, Elmore JR, Tromp G. Understanding the pathogenesis of abdominal aortic aneurysms. Expert Rev Cardiovasc Ther 2015; 13: 975-987 . DOI: 10.1586/14779072.2015.1074861
    CrossrefPubMedGoogle Scholar
  • 18 Tromp G, Weinsheimer S, Ronkainen A, Kuivaniemi H. Molecular basis and genetic predisposition to intracranial aneurysm. Ann Med 2014; 46: 597-606 . DOI: 10.3109/07853890.2014.949299
    CrossrefPubMedGoogle Scholar
  • 19 Jones GT, Tromp G, Kuivaniemi H, Gretarsdottir S, Baas AF, Giusti B. , et al. Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci. Circ Res 2017; 120: 341-353 . DOI: 10.1161/CIRCRESAHA.116.308765
    CrossrefPubMedGoogle Scholar
  • 20 El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol 2009; 6: 771-786 . DOI: 10.1038/nrcardio.2009.191
    PubMedGoogle Scholar
  • 21 Franken R, Groenink M, de Waard V, Feenstra HM, Scholte AJ, van den Berg MP. , et al. Genotype impacts survival in Marfan syndrome. Eur Heart J 2016; 37: 3285-3290 . DOI: 10.1093/eurheartj/ehv739
    CrossrefPubMedGoogle Scholar
  • 22 Baudhuin LM, Kotzer KE, Lagerstedt SA. Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants. J Hum Genet 2015; 60: 241-252 . DOI: 10.1038/jhg.2015.10
    CrossrefPubMedGoogle Scholar
  • 23 Frank M, Albuisson J, Ranque B, Golmard L, Mazzella JM, Bal-Theoleyre L. , et al. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. Eur J Hum Genet 2015; 23: 1657-1664 . DOI: 10.1038/ejhg.2015.32
    PubMedGoogle Scholar
  • 24 Shalhub S, Black 3rd JH, Cecchi AC, Xu Z, Griswold BF, Safi HJ. , et al. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. J Vasc Surg 2014; 60: 160-169 . DOI: 10.1016/j.jvs.2014.01.070
    CrossrefPubMedGoogle Scholar
  • 25 Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med 2014; 16: 881-888 . DOI: 10.1038/gim.2014.72
    PubMedGoogle Scholar
  • 26 Jondeau G, Ropers J, Regalado E, Braverman A, Evangelista A, Teixedo G. , et al. International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet 2016; 9: 548-558 . DOI: 10.1161/CIRCGENETICS.116.001485
    CrossrefPubMedGoogle Scholar
  • 27 Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera A. , et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet 2015; 8: 457-464 . DOI: 10.1161/CIRCGENETICS.114.000943
    CrossrefPubMedGoogle Scholar
  • 28 Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE. , et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Card 2010; 55: e27-e129 . DOI: 10.1016/j.jacc.2010.02.015
    CrossrefPubMedGoogle Scholar
  • 29 Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H. , et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2873-2926 . DOI: 10.1093/eurheartj/ehu281
    PubMedGoogle Scholar
  • 30 Schildmeyer LA, Braun R, Taffet G, Debiasi M, Burns AE, Bradley A. , et al. Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J 2000; 14: 2213-2220 . DOI: 10.1096/fj.99-0927com
    CrossrefPubMedGoogle Scholar
  • 31 Disabella E, Grasso M, Gambarin FI, Narula N, Dore R, Favalli V. , et al. Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). Heart 2011; 97: 321-326 . DOI: 10.1136/hrt.2010.204388
    CrossrefPubMedGoogle Scholar
  • 32 Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N. , et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007; 39: 1488-1493 . DOI: 10.1038/ng.2007.6
    CrossrefPubMedGoogle Scholar
  • 33 Heegaard AM, Corsi A, Danielsen CC, Nielsen KL, Jorgensen HL, Riminucci M. , et al. Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation 2007; 115: 2731-2738 . DOI: 10.1161/CIRCULATIONAHA.106.653980
    CrossrefPubMedGoogle Scholar
  • 34 Meester JA, Vandeweyer G, Pintelon I, Lammens M, Van Hoorick L, De Belder S. , et al. Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections. Genet Med 2017; 19: 386-395 . DOI: 10.1038/gim.2016.126
    PubMedGoogle Scholar
  • 35 Schwarze U, Hata R, McKusick VA, Shinkai H, Hoyme HE, Pyeritz RE. , et al. Rare autosomal rec[{AU: Please confirm or correct the conflict of interest statement. }]essive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet 2004; 74: 917-930 . DOI: 10.1086/420794
    CrossrefPubMedGoogle Scholar
  • 36 Smith LB, Hadoke PW, Dyer E, Denvir MA, Brownstein D, Miller E. , et al. Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome. Cardiovasc Res 2011; 90: 182-190 . DOI: 10.1093/cvr/cvq356
    CrossrefPubMedGoogle Scholar
  • 37 De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet 2012; 82: 1-11 . DOI: 10.1111/j.1399-0004.2012.01858.x
    CrossrefPubMedGoogle Scholar
  • 38 Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2007; 2: 32 . DOI: 10.1186/1750-1172-2-32
    CrossrefPubMedGoogle Scholar
  • 39 Monroe GR, Harakalova M, van der Crabben SN, Majoor-Krakauer D, Bertoli-Avella AM, Moll FL. , et al. Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1. Am J Med Genet A 2015; 167: 1196-1203 . DOI: 10.1002/ajmg.a.36997
    CrossrefPubMedGoogle Scholar
  • 40 Mehta S, Dhar SU, Birnbaum Y. Common iliac artery aneurysm and spontaneous dissection with contralateral iatrogenic common iliac artery dissection in classic Ehlers-Danlos syndrome. Int J Angiol 2012; 21: 167-170 . DOI: 10.1055/s-0032-1325118
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Wenstrup RJ, Meyer RA, Lyle JS, Hoechstetter L, Rose PS, Levy HP. , et al. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet Med 2002; 4: 112-117 . DOI: 10.1097/00125817-200205000-00003
    PubMedGoogle Scholar
  • 42 Huang J, Davis EC, Chapman SL, Budatha M, Marmorstein LY, Word RA. , et al. Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ Res 2010; 106: 583-592 . DOI: 10.1161/CIRCRESAHA.109.207852
    CrossrefPubMedGoogle Scholar
  • 43 Igoucheva O, Alexeev V, Halabi CM, Adams SM, Stoilov I, Sasaki T. , et al. Fibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalities. J Biol Chem 2015; 290: 21443-21459 . DOI: 10.1074/jbc.M115.640425
    CrossrefPubMedGoogle Scholar
  • 44 Jelsig AM, Urban Z, Hucthagowder V, Nissen H, Ousager LB. Novel ELN mutation in a family with supravalvular aortic stenosis and intracranial aneurysm. Eur J Med Genet 2017; 60: 110-113 . DOI: 10.1016/j.ejmg.2016.11.004
    CrossrefPubMedGoogle Scholar
  • 45 Callewaert B, Renard M, Hucthagowder V, Albrecht B, Hausser I, Blair E. , et al. New insights into the pathogenesis of autosomal-dominant cutis laxa with report of five ELN mutations. Hum Mutat 2011; 32: 445-455 . DOI: 10.1002/humu.21462
    CrossrefPubMedGoogle Scholar
  • 46 Szabo Z, Crepeau MW, Mitchell AL, Stephan MJ, Puntel RA, Yin Loke K. , et al. Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet 2006; 43: 255-258 . DOI: 10.1136/jmg.2005.034157
    PubMedGoogle Scholar
  • 47 Capuano A, Bucciotti F, Farwell KD, Tippin DB, Mroske C, Hulick PJ. , et al. Diagnostic exome sequencing identifies a novel gene, EMILIN1, associated with autosomal-dominant hereditary connective tissue disease. Hum Mutat 2016; 37: 84-97 . DOI: 10.1002/humu.22920
    CrossrefPubMedGoogle Scholar
  • 48 Pereira L, Andrikopoulos K, Tian J, Lee SY, Keene DR, Ono R. , et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet 1997; 17: 218-222 . DOI: 10.1038/ng1097-218
    CrossrefPubMedGoogle Scholar
  • 49 Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T. , et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 1999; 96: 3819-3823 . DOI: 10.1073/pnas.96.7.3819
    CrossrefPubMedGoogle Scholar
  • 50 Judge DP, Biery NJ, Keene DR, Geubtner J, Myers L, Huso DL. , et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 2004; 114: 172-181 . DOI: 10.1172/JCI20641
    CrossrefPubMedGoogle Scholar
  • 51 Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK. , et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-1121 . DOI: 10.1126/science.1124287
    CrossrefPubMedGoogle Scholar
  • 52 Lima BL, Santos EJ, Fernandes GR, Merkel C, Mello MR, Gomes JP. , et al. A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of FBN1 expression. PloS ONE 2010; 5: e14136 . DOI: 10.1371/journal.pone.0014136
    CrossrefPubMedGoogle Scholar
  • 53 Morris SA, Orbach DB, Geva T, Singh MN, Gauvreau K, Lacro RV. Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders. Circulation 2011; 124: 388-396 . DOI: 10.1161/CIRCULATIONAHA.110.990549
    CrossrefPubMedGoogle Scholar
  • 54 Takeda N, Morita H, Fujita D, Inuzuka R, Taniguchi Y, Imai Y. , et al. Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: case report and review of literature. Am J Med Genet A 2015; 167A: 2382-2387 . DOI: 10.1002/ajmg.a.37162
    PubMedGoogle Scholar
  • 55 Retailleau K, Arhatte M, Demolombe S, Jodar M, Baudrie V, Offermanns S. , et al. Smooth muscle filamin A is a major determinant of conduit artery structure and function at the adult stage. Pflugers Arch 2016; 468: 1151-1160 . DOI: 10.1007/s00424-016-1813-x
    CrossrefPubMedGoogle Scholar
  • 56 Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F. , et al. Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 2006; 103: 19836-19841 . DOI: 10.1073/pnas.0609628104
    CrossrefPubMedGoogle Scholar
  • 57 Reinstein E, Frentz S, Morgan T, García-Miñaúr S, Leventer RJ, McGillivray G. , et al. Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. Eur J Hum Genet 2013; 21: 494-502 . DOI: 10.1038/ejhg.2012.209
    PubMedGoogle Scholar
  • 58 Lange M, Kasper B, Bohring A, Rutsch F, Kluger G, Hoffjan S. , et al. 47 patients with FLNA associated periventricular nodular heterotopia. Orphanet J Rare Dis 2015; 10: 134 . DOI: 10.1186/s13023-015-0331-9
    CrossrefPubMedGoogle Scholar
  • 59 Kuang SQ, Medina-Martinez O, Guo DC, Gong L, Regalado ES, Reynolds CL. , et al. FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. J Clin Invest 2016; 126: 948-961 . DOI: 10.1172/JCI83778
    CrossrefPubMedGoogle Scholar
  • 60 Lee VS, Halabi CM, Hoffman EP, Carmichael N, Leshchiner I, Lian CG. , et al. Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci USA 2016; 113: 8759-8764 . DOI: 10.1073/pnas.1601442113
    CrossrefPubMedGoogle Scholar
  • 61 Hornstra IK, Birge S, Starcher B, Bailey AJ, Mecham RP, Shapiro SD. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 2003; 278: 14387-14393 . DOI: 10.1074/jbc.M210144200
    CrossrefPubMedGoogle Scholar
  • 62 Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI. , et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 2002; 106: 2503-2509 . DOI: 10.1161/01.CIR.0000038109.84500.1E
    CrossrefPubMedGoogle Scholar
  • 63 Ren W, Liu Y, Wang X, Jia L, Piao C, Lan F. , et al. β-Aminopropionitrile monofumarate induces thoracic aortic dissection in C57BL/6 mice. Sci Rep 2016; 6: 28149 . DOI: 10.1038/srep28149
    CrossrefPubMedGoogle Scholar
  • 64 Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B. , et al. MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet 2015; 96: 170-177 . DOI: 10.1016/j.ajhg.2014.11.015
    CrossrefPubMedGoogle Scholar
  • 65 Combs MD, Knutsen RH, Broekelmann TJ, Toennies HM, Brett TJ, Miller CA. , et al. Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo. J Biol Chem 2013; 288: 28869-28880 . DOI: 10.1074/jbc.M113.497727
    CrossrefPubMedGoogle Scholar
  • 66 Bellini C, Wang S, Milewicz DM, Humphrey JD. Myh11(R247C/R247C) mutations increase thoracic aorta vulnerability to intramural damage despite a general biomechanical adaptivity. J Biomech 2015; 48: 113-121 . DOI: 10.1016/j.jbiomech.2014.10.031
    CrossrefPubMedGoogle Scholar
  • 67 Pannu H, Tran-Fadulu V, Papke CL, Scherer S, Liu Y, Presley C. , et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 2007; 16: 2453-2462 . DOI: 10.1093/hmg/ddm201
    CrossrefPubMedGoogle Scholar
  • 68 Wang L, Guo DC, Cao J, Gong L, Kamm KE, Regalado E. , et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet 2010; 87: 701-707 . DOI: 10.1016/j.ajhg.2010.10.006
    CrossrefPubMedGoogle Scholar
  • 69 McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt 3rd TM. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007; 134: 290-296 . DOI: 10.1016/j.jtcvs.2007.02.041
    CrossrefPubMedGoogle Scholar
  • 70 Proost D, Vandeweyer G, Meester JA, Salemink S, Kempers M, Ingram C. , et al. Performant mutation identification using targeted next-generation sequencing of 14 thoracic aortic aneurysm genes. Hum Mutat 2015; 36: 808-814 . DOI: 10.1002/humu.22802
    CrossrefPubMedGoogle Scholar
  • 71 Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ. , et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet 2013; 93: 398-404 . DOI: 10.1016/j.ajhg.2013.06.019
    CrossrefPubMedGoogle Scholar
  • 72 Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D. , et al. Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 2012; 44: 1249-1254 . DOI: 10.1038/ng.2421
    CrossrefPubMedGoogle Scholar
  • 73 Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B. , et al. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat 2008; 29: 150-158 . DOI: 10.1002/humu.20623
    CrossrefPubMedGoogle Scholar
  • 74 Micha D, Guo DC, Hilhorst-Hofstee Y, van Kooten F, Atmaja D, Overwater E. , et al. SMAD2 mutations are associated with arterial aneurysms and dissections. Hum Mutat 2015; 36: 1145-1149 . DOI: 10.1002/humu.22854
    CrossrefPubMedGoogle Scholar
  • 75 Tan CK, Tan EH, Luo B, Huang CL, Loo JS, Choong C. , et al. SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS. J Am Heart Assoc 2013; 2: e000269 . DOI: 10.1161/JAHA.113.000269
    PubMedGoogle Scholar
  • 76 van der Linde D, van de Laar IM, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, Mattace-Raso FU. , et al. Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol 2012; 60: 397-403 . DOI: 10.1016/j.jacc.2011.12.052
    CrossrefPubMedGoogle Scholar
  • 77 van de Laar IM, van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-Zeinstra SM. , et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 2012; 49: 47-57 . DOI: 10.1136/jmedgenet-2011-100382
    CrossrefPubMedGoogle Scholar
  • 78 Zhang P, Hou S, Chen J, Zhang J, Lin F, Ju R. , et al. SMAD4 deficiency in smooth muscle cells initiates the formation of aortic aneurysm. Circ Res 2016; 118: 388-399 . DOI: 10.1161/CIRCRESAHA.115.308040
    CrossrefPubMedGoogle Scholar
  • 79 Heald B, Rigelsky C, Moran R, LaGuardia L, O’Malley M, Burke CA. , et al. Prevalence of thoracic aortopathy in patients with juvenile Polyposis Syndrome-Hereditary Hemorrhagic Telangiectasia due to SMAD4. Am J Med Genet A 2015; 167A: 1758-1762 . DOI: 10.1002/ajmg.a.37093
    PubMedGoogle Scholar
  • 80 Wain KE, Ellingson MS, McDonald J, Gammon A, Roberts M, Pichurin P. , et al. Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Genet Med 2014; 16: 588-593 . DOI: 10.1038/gim.2014.5
    PubMedGoogle Scholar
  • 81 Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J. , et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 2012; 44: 922-927 . DOI: 10.1038/ng.2349
    CrossrefPubMedGoogle Scholar
  • 82 Boileau C, Guo DC, Hanna N, Regalado ES, Detaint D, Gong L. , et al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 2012; 44: 916-921 . DOI: 10.1038/ng.2348
    CrossrefPubMedGoogle Scholar
  • 83 Renard M, Callewaert B, Malfait F, Campens L, Sharif S, del Campo M. , et al. Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2. Int J Card 2013; 165: 584-587 . DOI: 10.1016/j.ijcard.2012.09.029
    CrossrefPubMedGoogle Scholar
  • 84 Bertoli-Avella AM, Gillis E, Morisaki H, Verhagen JM, de Graaf BM, van de Beek G. , et al. Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J Am Coll Cardiol 2015; 65: 1324-1336 . DOI: 10.1016/j.jacc.2015.01.040
    CrossrefPubMedGoogle Scholar
  • 85 Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D. , et al. Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest 2014; 124: 448-460 . DOI: 10.1172/JCI69666
    CrossrefPubMedGoogle Scholar
  • 86 MacCarrick G, Black 3rd JH, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL. , et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med 2014; 16: 576-587 . DOI: 10.1038/gim.2014.11
    PubMedGoogle Scholar
  • 87 Boodhwani M, Andelfinger G, Leipsic J, Lindsay T, McMurtry MS, Therrien J. , et al. Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Can J Cardiol 2014; 30: 577-589 . DOI: 10.1016/j.cjca.2014.02.018
    CrossrefPubMedGoogle Scholar
  • 88 Attias D, Stheneur C, Roy C, Collod-Beroud G, Detaint D, Faivre L. , et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 2009; 120: 2541-2549 . DOI: 10.1161/CIRCULATIONAHA.109.887042
    CrossrefPubMedGoogle Scholar
  • 89 Teixido-Tura G, Franken R, Galuppo V, Gutierrez Garcia-Moreno L, Borregan M, Mulder BJ. , et al. Heterogeneity of aortic disease severity in patients with Loeys-Dietz syndrome. Heart 2016; 102: 626-632 . DOI: 10.1136/heartjnl-2015-308535
    CrossrefPubMedGoogle Scholar
  • 90 Tran-Fadulu V, Pannu H, Kim DH, Vick 3rd GW, Lonsford CM, Lafont AL. , et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009; 46: 607-613 . DOI: 10.1136/jmg.2008.062844
    CrossrefPubMedGoogle Scholar
  • 91 Wenstrup RJ, Florer JB, Davidson JM, Phillips CL, Pfeiffer BJ, Menezes DW. , et al. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem 2006; 281: 12888-12895 . DOI: 10.1074/jbc.M511528200
    CrossrefPubMedGoogle Scholar
  • 92 Park AC, Phillips CL, Pfeiffer FM, Roenneburg DA, Kernien JF, Adams SM. , et al. Homozygosity and heterozygosity for null COL5A2 alleles produce embryonic lethality and a novel classic Ehlers-Danlos syndrome-related phenotype. Am J Pathol 2015; 185: 2000-2011 . DOI: 10.1016/j.ajpath.2015.03.022
    CrossrefPubMedGoogle Scholar
  • 93 Kuang SQ, Kwartler CS, Byanova KL, Pham J, Gong L, Prakash SK. , et al. Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells. Circ Res 2012; 110: 1411-1422 . DOI: 10.1161/CIRCRESAHA.111.261743
    CrossrefPubMedGoogle Scholar
  • 94 Berk M, Desai SY, Heyman HC, Colmenares C. Mice lacking the SKI proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. Genes Dev 1997; 11: 2029-2039 . DOI: 10.1101/gad.11.16.2029
    CrossrefPubMedGoogle Scholar
  • 95 Zoppi N, Chiarelli N, Cinquina V, Ritelli M, Colombi M. GLUT10 deficiency leads to oxidative stress and non-canonical alphavbeta3 integrin-mediated TGFbeta signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts. Hum Mol Genet 2015; 24: 6769-6787 . DOI: 10.1093/hmg/ddv382
    CrossrefPubMedGoogle Scholar
  • 96 Cheng CH, Kikuchi T, Chen YH, Sabbagha NG, Lee YC, Pan HJ. , et al. Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc Res 2009; 81: 381-388 . DOI: 10.1093/cvr/cvn319
    PubMedGoogle Scholar
  • 97 Azhar M, Schultz JJ, Grupp I, Dorn 2nd GW, Meneton P, Molin DG. , et al. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev 2003; 14: 391-407 . DOI: 10.1016/S1359-6101(03)00044-3
    CrossrefPubMedGoogle Scholar